ERCOLINO, TONINO
 Distribuzione geografica
Continente #
NA - Nord America 3.395
EU - Europa 2.270
AS - Asia 1.572
SA - Sud America 209
AF - Africa 48
OC - Oceania 20
Totale 7.514
Nazione #
US - Stati Uniti d'America 3.342
RU - Federazione Russa 767
IT - Italia 473
SG - Singapore 457
PL - Polonia 374
CN - Cina 340
HK - Hong Kong 250
SE - Svezia 178
BR - Brasile 166
VN - Vietnam 164
IE - Irlanda 147
KR - Corea 126
FR - Francia 65
DE - Germania 63
FI - Finlandia 63
JO - Giordania 48
GB - Regno Unito 45
IN - India 40
BD - Bangladesh 38
CA - Canada 35
CH - Svizzera 26
ID - Indonesia 26
AR - Argentina 20
AU - Australia 20
IQ - Iraq 16
BE - Belgio 15
JP - Giappone 15
TR - Turchia 15
NL - Olanda 13
MX - Messico 11
UA - Ucraina 11
CI - Costa d'Avorio 10
EC - Ecuador 10
ES - Italia 9
MA - Marocco 9
ZA - Sudafrica 7
NP - Nepal 6
CZ - Repubblica Ceca 5
NG - Nigeria 5
PH - Filippine 4
PY - Paraguay 4
UZ - Uzbekistan 4
AL - Albania 3
BJ - Benin 3
CO - Colombia 3
DZ - Algeria 3
HU - Ungheria 3
PK - Pakistan 3
TN - Tunisia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CR - Costa Rica 2
EG - Egitto 2
ET - Etiopia 2
IL - Israele 2
LT - Lituania 2
PS - Palestinian Territory 2
RO - Romania 2
TH - Thailandia 2
VE - Venezuela 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BW - Botswana 1
CL - Cile 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
HR - Croazia 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
MM - Myanmar 1
MY - Malesia 1
NI - Nicaragua 1
PR - Porto Rico 1
RE - Reunion 1
SA - Arabia Saudita 1
SC - Seychelles 1
SV - El Salvador 1
TW - Taiwan 1
Totale 7.514
Città #
Santa Clara 688
Ashburn 460
Warsaw 373
Singapore 362
Fairfield 272
Hong Kong 217
San Jose 178
Chandler 159
Dublin 147
Woodbridge 132
Seoul 126
Seattle 115
Cambridge 101
Milan 101
Ann Arbor 87
Beijing 86
Houston 85
Wilmington 83
Hefei 59
Council Bluffs 57
Buffalo 54
Altamura 50
Lawrence 50
Florence 46
Los Angeles 46
Ho Chi Minh City 41
Moscow 40
Rome 38
Hanoi 37
Princeton 37
Lauterbourg 35
Munich 35
The Dalles 32
New York 30
Boston 29
Jacksonville 27
Bern 24
Paris 23
Boardman 22
Jakarta 22
Melbourne 20
Shanghai 20
Helsinki 19
Kent 19
San Diego 19
Mumbai 17
São Paulo 17
Dallas 16
Brussels 15
Turku 15
Naples 14
Montreal 12
Tokyo 12
Medford 11
Abidjan 10
Haiphong 10
Bologna 9
Brooklyn 9
Izmir 9
Lappeenranta 9
Da Nang 8
Dong Ket 8
Turin 8
Amsterdam 7
Baghdad 7
Belo Horizonte 7
Clifton 7
Guangzhou 7
Redondo Beach 7
St Petersburg 7
Toronto 7
Chennai 6
Figino 6
Orem 6
Palermo 6
Phoenix 6
Venice 6
Yubileyny 6
Casablanca 5
Chicago 5
Elk Grove Village 5
Guayaquil 5
Hillsboro 5
Hải Dương 5
Pune 5
Abuja 4
Andover 4
Biên Hòa 4
Bremen 4
Buenos Aires 4
Cagliari 4
Genoa 4
London 4
Mexico City 4
Norwalk 4
Old Bridge 4
Tashkent 4
Tianjin 4
West Jordan 4
Bari 3
Totale 5.104
Nome #
Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling. 356
NEW INSIGHTS IN THE CLINICAL AND TRANSLATIONAL RELEVANCE OF miR483-5p IN ADRENOCORTICAL CANCER 305
DIAGNOSIS of ENDOCRINE DISEASE: SDHx mutations: Beyond pheochromocytomas and paragangliomas 296
Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model. 233
Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis. 232
15 YEARS OF PARAGANGLIOMA: Metabolism and pheochromocytoma/paraganglioma 217
DISSECTING THE ORIGIN OF INDUCIBLE BROWN FAT IN ADULT HUMANS THROUGH A NOVEL ADIPOSE STEM CELL MODEL FROM ADIPOSE TISSUE SURROUNDING PHEOCHROMOCYTOMA 211
Fascin-1 is a Novel Prognostic Biomarker Associated with Tumor Invasiveness in Adrenocortical Carcinoma. 206
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients 197
The role of PPAR-γ system in normal and tumoral corticotroph pituitary and adrenal cells. 194
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapy 185
Sunitinib in the therapy of malignant paragangliomas: Report on the efficacy in a sdhb mutation carrier and review of the literature 183
Uncommon clinical presentations of pheochromocytoma and paraganglioma in two different patients affected by two distinct novel VHL germline mutations 181
SDHx and Non-Chromaffin Tumors: A Mediastinal Germ Cell Tumor Occurring in a Young Man with Germline SDHB Mutation 181
Caratterizzazione genomica del carcinoma surrenalico 180
A multicenter epidemiological study on second malignancy in non-syndromic pheochromocytoma/paraganglioma patients in Italy 180
Yeast model for evaluating the pathogenic significance of SDHB, SDHC and SDHD mutations in PHEO-PGL syndrome. 172
Mitochondrial function and content in Pheochromocytoma/paraganglioma of succinate dehydrogenase mutation carriers 172
Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study 170
MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma 169
Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma 168
Targeted Next Generation Sequencing molecular profiling and its clinical application in adrenocortical cancer 166
Novel Germline PHD2 Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia 166
Carbonic anhydrases III and IX are new players in the crosstalk between adrenocortical carcinoma and its altered adipose microenvironment 165
Clinical relevance of phenotype/genotype correlations in the diagnosis and therapy of pheochromocytomas/paragangliomas. 164
Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation 162
Prognostic and monitoring value of circulating tumour cells in adrenocortical carcinoma: a preliminary monocentric study. 161
Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma 156
Stimulated expression of CXCL12 in adrenocortical carcinoma by the ppargamma ligand rosiglitazone impairs cancer progression 156
Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience 154
Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer 151
Prognostic Value of Microscopic Tumor Necrosis in Adrenal Cortical Carcinoma 151
Occurrence of medullary thyroid carcinoma, bronchial carcinoid tumor, and papillary thyroid carcinoma in a family bearing the RET G691S polymorphism. 149
Malignant extra-adrenal pheochromocytoma caused by an SDHB intronic variation leading to a 54-bp deletion in exon 4. 147
Outcome and genetic analysis of patients affected by retinal capillary hemangioblastoma in von hippel lindau syndrome 147
Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas 145
Patient affected by neurofibromatosis type 1 and thyroid C-cell hyperplasia harboring pathogenic germ-line mutations in both NF1 and RET genes. 143
Pheochromocytoma in rats with multiple endocrine neoplasia (MENX) shares gene expression patterns with human pheochromocytoma 134
PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics 134
Potential pitfalls of SDH immunohistochemical detection in paragangliomas and phaeochromocytomas harbouring germline SDHx gene mutation 125
Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis. 117
Pros and cons of surgical versus conservative management for head and neck paraganglioma: a real-world data analysis 103
An innovative nuclear antigen-based approach for single-cell isolation of circulating tumor cells in adrenal cortical carcinoma 47
Presurgical Succinate MetAstatic Risk Tool (P-SMART) in Paragangliomas 44
Totale 7.575
Categoria #
all - tutte 21.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.431


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022277 11 25 24 13 10 12 14 31 7 18 45 67
2022/2023766 59 174 32 46 53 111 92 31 114 9 15 30
2023/2024333 11 32 41 16 20 46 11 67 13 26 42 8
2024/20252.045 59 207 130 370 516 306 44 149 51 63 74 76
2025/20262.573 283 319 170 160 294 103 347 121 158 205 80 333
2026/202749 49 0 0 0 0 0 0 0 0 0 0 0
Totale 7.575